Bulletin 2010/31 - European Patent Office
08.04.2013 • Views
Share Embed Flag

Bulletin 2010/31 - European Patent Office

Bulletin 2010/31 - European Patent Office

Bulletin 2010/31 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) I.1(1)<br />

KAMERLING, Steven, Glenn, Kalamazoo, MI<br />

49001, US<br />

(74) Brunetti, Fabrizio, Pfizer <strong>European</strong> <strong>Patent</strong><br />

Department 23-25 avenue du Docteur Lannelongue,<br />

75668 Paris Cedex 14, FR<br />

A61K <strong>31</strong>/7064 → (51) A61K 38/00<br />

(51) A61K <strong>31</strong>/7068 (11) 2 211 870 A1*<br />

A61P 35/02 A61P 43/00<br />

(25) En (26) En<br />

(21) 08845256.0 (22) 03.11.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) US 2008/012430 03.11.2008<br />

(87) WO 2009/058394 2009/19 07.05.2009<br />

(30) 01.11.2007 US 984638 P<br />

06.12.2007 US 992781 P<br />

05.03.2008 US 34093<br />

04.08.2008 US 86069<br />

21.08.2008 US 90852<br />

(54) • CYTIDINANALOGA ZUR BEHANDLUNG<br />

VON MYELODYSPLASTISCHEM SYN-<br />

DROM<br />

• CYTIDINE ANALOGS FOR TREATMENT OF<br />

MYELODYSPLASTIC SYNDROMES<br />

• ANALOGUES DE LA CYTIDINE DESTINÉS<br />

AU TRAITEMENT DE SYNDROMES MYÉ-<br />

LODYSPLASIQUES<br />

(71) CELGENE CORPORATION, 86 Morris Avenue,<br />

Summit, NJ 07901, US<br />

(72) BEACH, C.L., Less Summit MO 64081, US<br />

BACKSTROM, Jay, Thomas, Leawood KS<br />

66224, US<br />

(74) Ritter, Thomas Kurt, Jones Day<br />

Prinzregentenstraße 11, 80538 München, DE<br />

A61K <strong>31</strong>/7084 → (51) A23L 1/237<br />

A61K <strong>31</strong>/7105 → (51) A61K 38/43<br />

A61K <strong>31</strong>/7115 → (51) C12N 15/11<br />

(51) A61K <strong>31</strong>/713 (11) 2 211 871 A1*<br />

A61K 48/00 A61K <strong>31</strong>/00<br />

A61K 39/395 C12N 9/06<br />

C12N 15/53 C12N 15/11<br />

A61P 35/00<br />

(25) En (26) En<br />

(21) 08843507.8 (22) 15.10.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) FI 2008/050577 15.10.2008<br />

(87) WO 2009/056671 2009/19 07.05.2009<br />

(30) 30.10.2007 FI 20070820<br />

04.01.2008 US 19005<br />

(54) • VERFAHREN ZUR ANGIOGENESEHEM-<br />

MUNG ODER ZUR KREBSBEHANDLUNG<br />

• METHOD FOR INHIBITING ANGIOGENESIS<br />

OR FOR TREATMENT OF CANCER<br />

• PROCÉDÉ POUR INHIBER L'ANGIOGE-<br />

NÈSE OU POUR TRAITER LE CANCER<br />

(71) Faron Ventures OY, Tykistökatu 6 B, 20520<br />

Turku, FI<br />

(72) SALMI, Marko, FI-20900 Turku, FI<br />

JALKANEN, Sirpa, FI-20760 Piispanristi, FI<br />

(74) Öhman, Ann-Marie, Kaivokatu 15 B 23, FIN-<br />

20520 Turku, FI<br />

(51) A61K <strong>31</strong>/765 (11) 2 211 872 A1*<br />

A61P 9/00<br />

(25) En (26) En<br />

(21) 08845029.1 (22) <strong>31</strong>.10.2008<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) CA 2008/001934 <strong>31</strong>.10.2008<br />

(87) WO 2009/055935 2009/19 07.05.2009<br />

(30) 02.11.2007 US 996137 P<br />

(54) • HYPERVERZWEIGTES POLYGLYCEROL<br />

ZUR VERBESSERUNG DER HERZFUNK-<br />

TION<br />

• HYPERBRANCHED POLYGLYCEROL FOR<br />

IMPROVING HEART FUNCTION<br />

• POLYGLYCÉROL HYPERRAMIFIÉ POUR<br />

AMÉLIORER LA FONCTION CARDIAQUE<br />

(71) The University Of British Columbia, University<br />

- Industry Liaison <strong>Office</strong> 103 - 6190<br />

Agronomy Road, Vancover, BC V6T 1Z3, CA<br />

(72) ALLARD, Michael, Vancouver British<br />

Columbia V6N 3A2, CA<br />

PODOR, Thomas, J., Lions Bay British<br />

Columbia V0N 2E0, CA<br />

BROOKS, Donald, E., Vancouver British<br />

Columbia V6S 1C9, CA<br />

KAINTHAN, Rajesh, K., Quincy MA 02171,<br />

US<br />

(74) Ward, Siobhan, Harrison Goddard Foote 40-<br />

43 Chancery Lane, London WC2A 1JA, GB<br />

A61K 33/04 → (51) C01B 19/00<br />

(51) A61K 33/10 (11) 2 211 873 A1*<br />

C07K 14/435<br />

(25) En (26) En<br />

(21) 08842462.7 (22) 22.10.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) IL 2008/001362 22.10.2008<br />

(87) WO 2009/053967 2009/18 30.04.2009<br />

(30) 22.10.2007 IL 18685007<br />

14.08.2008 IL 19346108<br />

(54) • STABILES AMORPHES CALCIUMCARBO-<br />

NAT MIT PHOSPHORYLIERTEN AMINO-<br />

SÄUREN, SYNTHETISCHEN<br />

PHOSPHORYLIERTEN PEPTIDEN UND<br />

GASTROLITH-PROTEINEN<br />

• STABLE AMORPHOUS CALCIUM CARBO-<br />

NATE COMPRISING PHOSPHORYLATED<br />

AMINO ACIDS, SYNTHETIC PHOSPHORY-<br />

LATED PEPTIDES, AND GASTROLITH<br />

PROTEINS<br />

• CARBONATE DE CALCIUM AMORPHE<br />

STABLE COMPRENANT DES ACIDES<br />

AMINÉS PHOSPHORYLÉS, DES PEPTIDES<br />

PHOSPHORYLÉS SYNTHÉTIQUES ET DES<br />

PROTÉINES DE GASTROLITHES<br />

(71) Amorphical Ltd., P.O.B. 15021, Beer Sheva<br />

84120, IL<br />

(72) BENTOV, Shmuel, 99850 M.p. Ha'ela, IL<br />

SAGI, Amir, 84965 Omer, IL<br />

BERMAN, Amir, 84965 Omer, IL<br />

SHECHTER, Assaf, 64245 Tel Aviv, IL<br />

(74) Bonvicini, Davide, Perani Mezzanotte &<br />

Partners Piazza San Babila, 5, 20122 Milano,<br />

IT<br />

(60) 1016<strong>31</strong>43.0<br />

A61K 33/14 → (51) A23L 1/237<br />

A61K 33/26 → (51) A61K 49/18<br />

A61K 33/34 → (51) A61K <strong>31</strong>/47<br />

(51) A61K 33/42 (11) 2 211 874 A1*<br />

A61M 1/28 A61M 1/16<br />

A61L 2/02 A61L 2/04<br />

A61L 2/07 A61L 2/10<br />

52<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>31</strong>/<strong>2010</strong>) 04.08.<strong>2010</strong><br />

A61P 7/08<br />

(25) En (26) En<br />

(21) 08838014.2 (22) 07.10.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) US 2008/079010 07.10.2008<br />

(87) WO 2009/048849 2009/16 16.04.2009<br />

(30) 11.10.2007 US 871018<br />

(54) • PYROPHOSPHATE ENTHALTENDE STERI-<br />

LISIERTE DIALYSELÖSUNGEN<br />

• STERILISED DIALYSIS SOLUTIONS CON-<br />

TAINING PYROPHOSPHATES<br />

• SOLUTIONS DE DIALYSE STÉRILISÉES<br />

CONTENANT DU PYROPHOSPHATE<br />

(71) Baxter International Inc., One Baxter Parkway,<br />

Deerfield, IL 60015-4633, US<br />

Baxter Healthcare S.A., Hertistrasse 2 Wallisellen,<br />

8304 Zurich, CH<br />

(72) RISER, Bruce L., Kenosha Wisconsin 51340,<br />

US<br />

ZIESKE, Paul, Glenview Illinois 60026, US<br />

KAROOR, Sujatha, Lake Forest Illinois<br />

60045, US<br />

PATEL, Himanshu D., Gurnee Illinois 600<strong>31</strong>,<br />

US<br />

(74) Dee, Ian Mark, et al, Potter Clarkson LLP<br />

Park View House 58 The Ropewalk, Nottingham<br />

NG1 5DD, GB<br />

(51) A61K 35/12 (11) 2 211 875 A1*<br />

C12N 5/06 A61P 1/16<br />

A61P 13/12<br />

(25) En (26) En<br />

(21) 07849722.9 (22) 29.10.2007<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) IT 2007/000753 29.10.2007<br />

(87) WO 2009/057165 2009/19 07.05.2009<br />

(54) • VERWENDUNG VON MIKROVESIKELN<br />

(MVS) AUS STAMMZELLEN ZUR HER-<br />

STELLUNG EINES MEDIKAMENTS ZUR<br />

ENDO/EPITHELIALEN REGENERATION<br />

VON VERLETZTEN ODER GESCHÄDIGTEN<br />

GEWEBEN ODER ORGANEN UND RELE-<br />

VANTE IN-VITRO- UND IN-VIVO-VERFAH-<br />

REN<br />

• USE OF MICROVESICLES (MVS) DERIVED<br />

FROM STEM CELLS FOR PREPARING A<br />

MEDICAMENT FOR ENDO/EPITHELIAL<br />

REGENERATION OF DAMAGED OR<br />

INJURED TISSUES OR ORGANS, AND<br />

RELATED IN VITRO AND IN VIVO METH-<br />

ODS<br />

• UTILISATION DE MICROVÉSICULES (MV)<br />

DÉRIVÉES DE CELLULES-SOUCHES POUR<br />

LA PRÉPARATION D'UN MÉDICAMENT<br />

DESTINÉ LA RÉGÉNÉRATION ENDOTHÉ-<br />

LIALE/ÉPITHÉLIALE DE TISSUS OU D'OR-<br />

GANES ENDOMMAGÉS OU LÉSÉS, ET<br />

PROCÉDÉS IN VITRO ET IN VIVO ASSO-<br />

CIÉS<br />

(71) Fresenius Medical Care Deutschland GmbH,<br />

Else-Kröner-Strasse 1, 61352 Bad Homburg,<br />

DE<br />

(72) CANTALUPPI, Vincenzo, I-22038 Tavernerio<br />

(Como), IT<br />

DEREGIBUS, Maria Chiara Amilde, I-10132<br />

Torino, IT<br />

CAMUSSI, Giovanni, I-10132 Torino, IT<br />

(74) Comoglio, Elena, et al, Jacobacci & Partners<br />

S.p.A. Corso Emilia 8, 10152 Torino, IT<br />

(51) A61K 35/24 (11) 2 211 876 A1*<br />

(25) En (26) En

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!